Glizato M 80mg/500mg Tablet is a combination oral antidiabetic medication containing Gliclazide 80mg and Metformin 500mg, indicated for the management of type 2 diabetes mellitus. Gliclazide, a sulfonylurea class agent, functions by stimulating pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily decreases hepatic glucose production and improves peripheral insulin sensitivity, enhancing glucose uptake and utilization. The synergistic effect of these two agents provides improved glycemic control in patients inadequately managed by diet, exercise, or monotherapy. Glizato M is typically prescribed as part of a comprehensive diabetes management plan including lifestyle modifications such as diet and physical activity. The medication should be used with caution in patients with renal or hepatic impairment, and regular monitoring of blood glucose, renal function, and potential adverse effects is recommended. Common side effects may include gastrointestinal disturbances, hypoglycemia, and rarely, lactic acidosis. Dose adjustments may be necessary based on therapeutic response and tolerability. Glizato M 80mg/500mg Tablet offers an effective option for optimizing glycemic control in type 2 diabetes, aiming to reduce the risk of diabetes-related complications.

Dosage & How to Use